Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 100 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $24.266 million which beat the analyst consensus estimate of $22.312 million by 8.76 percent. This is a 40.41 percent increase over sales of $17.282 million the same period last year.